Latest News

Germany to pump €1bn into breakthrough innovation

German Research Minister Anja Karliczek and Economics Minister Peter Altmaier make a joint statement on the founding of the Agency for Jump Innovations following the meeting of the Federal Cabinet. © BMBF / Hans-Joachim Rickel


by tg

Germany’s government announced that it will create an agency for breakthrough ("jump") innovation to foster technology transfer of risky research projects with high market potential into products.

The German agency precede EU plans to create a similar EU agency within its next research framework programme starting in 2021. The agency will be funded with roughly €1bn over 10 years.

The move is intented to keep value creation in Germany.  The idea for such an agency is lent from the US agency DARPA (Defense Advanced Research Projects Agency), which was founded by President Dwight D. Eisenhower in the 1950ies to support commercialisation of groundbreaking inventions such as the Internet, GPS or driverless vehicles. Besides Germany, Sweden and Switzerland have already established innovation agencies for non-military purposes. 

The German agency is set to start next year. According to Germany’s minister for economics, Peter Altmaier, a first call will seek for 3 to 4 promising artificial intelligence projects.

Researchers unravel how ADEP antibiotics work

Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...

iStar Medical SA raises €40.1m

Earlybird and BNP Paribas Fortis Private Equity and existing shareholders including Capricorn Partners, Walloon Region Investment Fund (SRIW) and...

Immatics and Celgene enter $1.5bn deal

Under the agreement, Celgene secures exclusive options to three "T-Cell receptor engineered T-cell therapy" (TCR-T) solid tumour targets...

ADC Therapeutics and Freenome enter biomarker collaboration

Under the biomarker development collaboration, ADC Therapeutics SA (Lausanne) will employ Freenome's multiomics platform to identify biomarkers that...

Versantis raises CHF16m in Series B financing

The CHF16m Series B financing was led by Swisscanto Invest by Zürcher Kantonalbank with co-financing by Esperante Venture, investiere, Redalpine...

Novo Nordisk enters haemophilia gene therapy field

Changes in the treatment standard of haemophilia A, such as Roche’s 2017 launch of Hemlibra, have put Novo Nordisk’s revenues (in the US$15.8bn...

New malaria lead kills 99.9% of pathogens

The researchers built on the fact, that Plasmodium is highly dependent on external supply and metabolisation of vitamin B 5 (pantothenamide). They...